4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Medexus Pharmaceuticals Inc. (MDP) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toronto, Canada with about 90 employees. Its market capitalization is roughly $169 million. In the fiscal year ended 2026-03-31, MDP reported $99M in revenue and ($2M) in net income.
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | $99M | $108M | $113M | $108M |
| Gross Profit | $54M | $57M | $60M | $60M |
| Operating Income (EBIT) | $6M | $12M | $13M | $8M |
| Net Income | ($2M) | $2M | ($0M) | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $25M | $25M | $25M | $25M | $25M | — |
| Gross Profit | $13M | $14M | $14M | $14M | $12M | — |
| Operating Income (EBIT) | $2M | $2M | $2M | $1M | ($0M) | — |
| Net Income | ($3M) | $0M | ($0M) | $0M | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | $147M | $172M | $156M | $161M | — |
| Total Liabilities | $98M | $120M | $125M | $139M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms